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OBJECTIVES 
 
The objectives of this study were to compare the colonization and prevalence rates in the nations 
of the United States, Sweden and Syria, with each country being representative of different 
demographics and treatment methods and to analyze the healthcare practices of each nation, 
specifically the rates at which each nation prescribes specific broad and narrow-spectrum 
antibiotics. Also, this study aimed to assess the refugee crisis, which has caused a massive 
migration of Syrians to Sweden, to make inquiries regarding the state of MRSA in nations like 
Sweden. The culmination of this research is the question does the way the United States 
prescribes antibiotics allow for more MRSA infections to occur and what future practices can 
be used to help make MRSA a less dangerous pathogen in all demographics? 
 
METHODS 
 
This was primarily a study which synthesized data from various reports and resources to form a 
coherent overview of MRSA infection patterns and propose further research methods for future 
studies. To represent various demographics and methods of MRSA treatment three nations were 
chosen. Sweden and the United States were identified as developed nations with similar wealth 
and MRSA colonization rates but different prevalence (7, 8). Syria was chosen to be compared to 
the United States and Sweden because it has a high documented MRSA colonization rate and is 
the source of large numbers of refugees who are fleeing to countries like Sweden (4, 8). Studies 
were then reviewed that documented several aspects of the MRSA threat in these nations, 
including methods of testing, diagnosis and treatment. The data obtained was interpreted so that 
conclusions could be drawn and further research objectives could be proposed. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
RESULTS AND FIGURES 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 1. Background information on demographics and 
economics in United States, Sweden and Syria (8). 
Table 2. The effects of the Syrian Civil War (7, 8).  
 
 
 
 
 
 
 
Figure 1. Colonization of MRSA by nation. 
MRSA colonization rates were based on official statistics presented by the CDC 
and CDDEP in the case of the United States and Sweden. The colonization rate for 
Syria was acquired by using congruent first hand studies and cross-referencing the 
rates found with known rates of colonization amongst well documented Syrian 
refugee populations in other countries. (4, 5, 6). 
 
 
 
 
Figure 2. Prevalence of MRSA in the United States and Sweden. 
The United States displays a MRSA prevalence of 2.6 infections per 
10,000 people. Sweden has 0.3 MRSA infections per 10,000 people 
equating to a rate that is 8 times lower than the United States’ despite 
similar colonization rates (3, 6). 
 
 
 
 
 
 
 
 
 
It was found that the United States and Sweden are on par in terms of wealth and MRSA 
colonization rate (2-4%). Syria, for various reasons, possesses a much higher colonization rate 
(15-20%) meaning that its population comes in contact with MRSA much more frequently (4, 7). 
Despite similarities, people in the United States are eight times as likely to develop a MRSA 
infection than people in Sweden (3, 6). Syria also has a problem with the availability and misuse 
of antibiotics that contributes to high colonization and infection rates of MRSA and other 
pathogens (1). The United States prescribes broad-spectrum antibiotics at much higher rates than 
Sweden does which would indicate that patients in the United States are subject to more depleted 
normal flora (7). Conversely, Sweden prescribes narrow-spectrum antibiotics at rates that far 
surpass the United States and Syria (7). Syrians are moving to Sweden in the midst of a refugee 
crisis at unprecedented rates (7, 8). 
 
DISCUSSION 
 
The United States and Sweden are similar enough in terms of wealth and development that it can 
be expected that they would have access to the same quality healthcare facilities, education and 
techniques that other countries, like Syria, may not be able to access for varying circumstances 
(8). It may be theorized that the difference in rates of infection between the United States and 
Sweden is a partial product of the way antibiotics are used in each country. The United States’ 
high use of broad-spectrum treatments would mean that patients in the United States are more 
likely to have significant portions of their normal flora inhibited (7). Since MRSA is 
opportunistic, patients with compromised normal flora are prime targets for infection (2). In stark 
contrast, Sweden’s high prescription rate of narrow-spectrum antibiotics is indicative of 
Figure 3. Antibiotic prescription trends in Sweden and the United States. 
Broad-spectrum antibiotic prescription rates are much higher in the United 
States than in Sweden. In contrast, Sweden prescribes narrow-spectrum 
antibiotics at a much higher rate (6). Syria (not shown) has rates of 
prescription which are hard to quantify as antibiotics are often unavailable, 
used incorrectly or recycled from past infections (1).  
 
increased antibiotic susceptibility testing (7). Prescribing antibiotics with mechanisms of action 
for specific infections rather than indiscriminately attacking pathogenic and normal flora is likely 
a contributing factor to Sweden’s low MRSA infection prevalence. While reliable data on MRSA 
in Syria is harder to obtain, the trend is clear that the sociopolitical conditions of the country are 
exacerbating the problems of MRSA. The worldwide migration trend of Syrians to other 
countries should be watched closely and provides new avenues for healthcare service and 
research as it pertains to MRSA and proper antibiotics use. 
 
IMPLICATIONS FOR FUTURE STUDY 
 
1. Further study on the methods of antibiotic susceptibility testing in Sweden and the United 
States should be conducted. Can effective methods be translated into a setting in an 
underserved area like Syria?  
 
2. Tracking the immigration and MRSA colonization rates amongst Syrian refugees and the 
European countries they enter. 
 
3. This study neglected to analyze the cost-effectiveness of antibiotic susceptibility testing 
in most cases and further research should focus on the economics of prescribing and 
testing. 
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